The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
 
Filippo De Marinis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
 
Byoung Chul Cho
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Roche; Yuhan
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Roche; Yuhan
 
Dong-Wan Kim
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Maximilian J. Hochmair
No Relationships to Disclose
 
Giulio Metro
Speakers' Bureau - Novartis
 
Johan F. Vansteenkiste
Honoraria - Lilly; MSD
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Novartis (Inst)
Research Funding - AstraZeneca (Inst)
 
David Vicente
No Relationships to Disclose
 
Benjamin J. Solomon
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb (Inst); Eisai; Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Veristrat (Biodesix)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; Roche
 
Parneet K. Cheema
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim; Proacta
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Pfizer; Proacta
 
Helano C. Freitas
Consulting or Advisory Role - Merck Sharp & Dohme; Roche
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Mariano Provencio
No Relationships to Disclose
 
Yuh-Min Chen
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; Lilly; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Roche
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)
 
Alvin Milner
Employment - AstraZeneca
 
James R. Rigas
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca